# Protective effects of a multicomponent toxin binder and organic acid blend on feed efficiency, oxidative status, hepatic histology, and jejunal immune–antioxidant responses in broilers co-challenged with aflatoxin B1 and Clostridium perfringens

**Authors:** Maryam Karimi Zandi, Hassan Shirzadi, Hossein Ali Ghasemi, Mohammad Amir Karimi Torshizi, Kamran Taherpour, Enayat Rahmatnejad

PMC · DOI: 10.1016/j.psj.2026.106546 · Poultry Science · 2026-01-29

## TL;DR

A blend of toxin binders and organic acids helps protect chickens from the harmful effects of aflatoxin and Clostridium perfringens.

## Contribution

The study introduces a multicomponent toxin binder and organic acid blend as an effective strategy for mitigating aflatoxin and bacterial co-challenges in broilers.

## Key findings

- The combination of MTB and OAB improved feed efficiency and oxidative status in co-challenged broilers.
- MTB+OAB reduced liver damage and normalized immune and antioxidant gene expression.
- Co-challenge with aflatoxin and C. perfringens caused greater detriments than aflatoxin alone.

## Abstract

This study evaluated the effects of a multicomponent toxin binder (MTB) and an organic acid blend (OAB) on performance, immunity, oxidative status, liver histology, and jejunal inflammatory/antioxidant gene expression in broilers challenged with aflatoxin B1 (AFB1) and Clostridium perfringens. A total of 420 Ross 308 broilers were assigned to seven groups (6 replicates × 10 birds): Control (unchallenged), A (AFB1), AM (AFB1 + MTB), AMO (AFB1 + MTB + OAB), AC (AFB1+ C. perfringens), ACM (AFB1 + C. perfringens + MTB), and ACMO (AFB1 + C. perfringens + MTB+OAB). AFB1 (500 ppb) was provided throughout days 0–42; C. perfringens (1 × 10⁸ CFU/mL) was administered on days 15–24. AFB1 alone, and more markedly the AFB1+C. perfringens co-challenge, reduced body-weight gain and feed efficiency, increased hepatic superoxide dismutase activity and malondialdehyde level, enlarged central-vein diameter, upregulated jejunal NF-κB1, TNF-α, and IL-6, and downregulated hepatic total antioxidant capacity and jejunal NRF2 and SOD1 mRNA expression (P < 0.05). The co-challenge also lowered Newcastle disease antibody titers, reduced phytohemagglutinin-induced toe-web swelling, and increased the heterophil:lymphocyte ratio (P < 0.05). Although MTB attenuated several AFB1-related impairments, MTB+OAB provided superior protection under co-challenge, increasing hepatic total antioxidant capacity, lowering malondialdehyde, improving liver histoarchitecture (central-vein diameter), and normalizing the expression of immune and antioxidant genes toward control levels, alongside improvements in performance indices (P < 0.05). In conclusion, although co-exposure to AFB1 and C. perfringens caused greater detriments than AFB1 alone, adding OAB to MTB improved performance, oxidative, histological, and immunological outcomes, supporting MTB+OAB as a practical strategy for broilers under concurrent mycotoxin–enteric challenge.

## Linked entities

- **Genes:** NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790], TNF (tumor necrosis factor) [NCBI Gene 7124], IL6 (interleukin 6) [NCBI Gene 3569], GABPA (GA binding protein transcription factor subunit alpha) [NCBI Gene 2551], SOD1 (superoxide dismutase 1) [NCBI Gene 6647]
- **Chemicals:** aflatoxin B1 (PubChem CID 186907), malondialdehyde (PubChem CID 10964)
- **Species:** Gallus gallus (taxon 9031), Clostridium perfringens (taxon 1502)

## Full-text entities

- **Diseases:** toe-web swelling (MESH:D000070592), inflammatory (MESH:D007249), Newcastle disease (MESH:D009521)
- **Chemicals:** AFB1 (MESH:D016604), AC (-), malondialdehyde (MESH:D008315)
- **Species:** Clostridium perfringens (species) [taxon 1502]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12919270/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12919270/full.md

## References

76 references — full list in the complete paper: https://tomesphere.com/paper/PMC12919270/full.md

---
Source: https://tomesphere.com/paper/PMC12919270